Efficacy and safety of dapagliflozin plus saxagliptin vs monotherapy as added to metformin in patients with type 2 diabetes: A meta-analysis

BACKGROUND: This study aim at evaluating the efficacy and safety of dapagliflozin plus saxagliptin vs monotherapy as added to metformin in patients with type 2 diabetes mellitus (T2DM). METHOD: PubMed, Cochrane library, Embase, CNKI and Wanfang databases were searched up to 31 December 2019. Randomi...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhuang, Yan, Song, Jin, Ying, Miaofa, Li, Mingxing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2020
Materias:
4300
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7386974/
https://www.ncbi.nlm.nih.gov/pubmed/32791755
http://dx.doi.org/10.1097/MD.0000000000021409

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7386974/
https://www.ncbi.nlm.nih.gov/pubmed/32791755
http://dx.doi.org/10.1097/MD.0000000000021409

Ejemplares similares